Related references
Note: Only part of the references are listed.Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes
Gian Paolo Fadini et al.
DIABETES CARE (2010)
Low CD34+cell count and metabolic syndrome synergistically increase the risk of adverse outcomes
Gian Paolo Fadini et al.
ATHEROSCLEROSIS (2009)
Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
Marc-Michael Zaruba et al.
CELL STEM CELL (2009)
Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy
H. Makino et al.
DIABETIC MEDICINE (2009)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
Significance of endothelial progenitor cells in subjects with diabetes
Gian Paolo Fadini et al.
DIABETES CARE (2007)
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats
G. P. Fadini et al.
DIABETOLOGIA (2006)
Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy
Gian Paolo Fadini et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Circulating endothelial progenitor cells and cardiovascular outcomes
N Werner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus
GP Fadini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes
PM Humpert et al.
DIABETES CARE (2005)
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
DJ Ceradini et al.
NATURE MEDICINE (2004)
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells
A Aicher et al.
NATURE MEDICINE (2003)
Share Paper
